A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)

Recruiting

Trial locations(5 sites)

United States

The Regents of the University of California, San Francisco, California

The Trustees of the University of Pennsylvania, Office of Clinical Research-Legal Services, Perelman School of Medicine, Philadelphia, Pennsylvania

Canada

Edmonton Clinic Health Academy (ECHA)- University of Alberta, Edmonton

Bone Research and Education Centre, Oakville

University Health Network (UHN) - Toronto General, Toronto